As part of our integrated product development services, we provide clinical trial material across small molecule applications for early and late phase clinical trials.

Clinical trial material (CTM) is manufactured for early and late phase clinical trials across oral, parenteral or inhaled applications.

  • Drug substances – intermediates, drug substances based on a full range of chemistry including HPAPI and ADC payloads 
  • Drug-product intermediates – micronized compounds, spray-dried compounds or dispersions, hot-melt extrudates
  • Finished drug products – immediate and modified release tablets, encapsulated multiparticulates or powder-based formulations, liquid-filled hard capsules and softgels

Small-scale processing is in place to provide CTM for non-GMP feasibility studies and cGMP development and clinical trial studies. Launch and commercial-scale production is also in place to support late-phase clinical supply and commercialization of drug substance, intermediates and/or finished drug products. Rapid development, scale-up and commercialization is facilitated with this phase-appropriate scale and the option for integrated services.

This on-demand webinar provides an overview of Lonza's clinical services, inclusive of integrated first-in-human solutions, which can effectively support accelerated timelines. Selected case studies are presented that demonstrate best practices in complex packaging and direct-to-patient supply.

View our webinar on-demand

Specialized Clinical Services for Complex Clinical Studies

Clinical trial material manufacturing

We are equipped to support non-GMP feasibility studies in addition to manufacturing phase-appropriate cGMP CTM thereby facilitating rapid advancement of your compound.

Specialized facilities are also in place to process high-potency drug compounds and to handle solvent-based processes, such as spray drying and spray-layered technology for multiparticulates. Analytical services and extensive process-development expertise ensure that the scale-up of processes is efficient and seamless.

In addition, full product development support is available on site, including GMP-compliant analytical laboratories, primary and secondary packaging services to support Phase I-V clinical projects, along with overall CTM worldwide distribution and storage services.

Technologies and products

related content

Lipid-Based Formulations for Early Stage Clinical Trials
Webinar on-demand
Manufacturing Amorphous Solid Dispersions by Spray-Drying: Scale-Up Approaches
Webinar slides
Micro-Dosing and Powder-in-Capsule Evaluations
Tech brief
Solid Dosage Manufacturing, Packaging and Distribution
Tech brief